Biomedical Excellence for Safer Transfusion
  • Biomedical Excellence for Safer Transfusion (BEST)
    Biomedical Excellence for Safer Transfusion (BEST)

    BEST Collaborative is an international research organization that works collaboratively to explore ways to improve transfusion-related services through…

  • BEST Membership
    BEST Membership

    The BEST collaborative is a unique free-standing group of over 150 manufacturers, clinicians, and scientists from 22 countries committed to improving transfusion…

  • BEST Meetings
    BEST Meetings

    BEST meetings are held twice per year. and attendance is open to all members. Invited guests may attend with pre-approval of the Chair.

  • Press Releases
    Press Releases

    Official notices regarding significant publications, special events and member news.

  • Recommended Procedures
    Recommended Procedures

    Several best practice documents are available for download

  • Sponsorship

    Any commercial organization or Blood Service interested in advancing the purpose of BEST may become a supporter of BEST by paying the annual dues amount; providing a…

Latest News

Call for Scientific Applications

The application period for Scientific Applications is now closed.

Press Release 13 Dec 2017

Ziggy Szczepiorkowski, MD, PhD elected Chair, effective Oct 2018

Transfusion Update Event

was held in Sydney Australia in April 2017.

Member Reminders

  • Thank you to all who attended the Florence Meeting!
  • Meeting presentations from the Florence Meeting will be posted in the coming weeks. These will be available to members only.
  • Information on the meeting in Newport, Rhode Island to be held prior to the Boston AABB Meeting in October will be posted in June.
  • Applications for Scientific Membership are under review. The application period has now closed.

April 2018


BEST LV Meeting

Dates for the Meeting in Florence, Italy were April 27-28, 2018.

Important News

  • The meeting location was the FH-Grand Hotel Mediterraneo
  • The BEST Book is available for download for members
  • Meeting presentations will be posted in the coming weeks


October 2018

Newport RI

BEST LVI Meeting

The meeting dates for the Fall Meeting are October 10-11, 2018.


  • The Newport Harbor Hotel & Marina, Newport, Rhode Island
  • Immediately prior to the AABB Meeting in Boston
  • Room reservations will be available mid-June 2018
  • Note that this will be a full 2-day meeting!



The Cellular Therapy Team 

Members of this team work at leading institutions in North America, Europe, Australia, and Asia. Key objectives of the team are to survey current practice in the preparation, assessment, storage and distribution of cellular therapy products and to perform detailed laboratory studies in selected areas of interest. 

Recent and current studies include:

  • Interlaboratory proficiency testing of cord blood stem cell collections
  • Intra and interlaboratory proficiency testing of dendritic cell products for immunotherapy protocols
  • Assessment of stem cell storage and transportation aiming to define best practice
  • Understanding the key release criteria for cellular therapy products
  • Standardisation of colony forming units and other key parameters for the assessment of hematopoietic stem cells
  • Measurement of viability of cellular therapy products

The BEST cellular therapy team works closely with international organisations such as AABB, ISCT and EBMT in surveying current practice and its laboratory-based projects are conducted by expert scientists at leading institutions around the world. The results of all studies are published in leading scientific journals such as Transfusion and Cytotherapy. A list of recent publications is to be found on the website. We are keen to continue to forge new scientific links with researchers in other leading academic organisations and with key manufacturers of products used in the field of cellular therapy. We are committed to expanding our interests further into the fields of immunotherapy and regenerative medicine as these are developed for clinical study and subsequent routine application in specific patient groups. We hope that you share our belief that the horizons of cellular therapy are ever-expanding.

The team leaders for Cell Therapy are Ziggy Szczepiorkowski. MD, PhD, Dartmouth, US and David McKenna, MD, University of Minnesota, US.